PreslavaDilkova

Of Counsel

ブリュッセル + 32.2.645.14.53

Connect:

共有

Preslava Dilkova advises on EU regulatory compliance cases, focusing on EU chemicals regulation, including REACH (Registration, Evaluation, Authorization and Restriction of Chemicals), the CLP Regulation (classification, labelling, and packaging), and the Biocidal Products Regulation.

For nearly a decade, Preslava has counseled on all aspects of REACH (registrations, compliance checks and substance evaluation cases, authorizations, and restrictions). She is closely involved in the management of several REACH registration and authorization consortia ranging from three to 280 participants. She also regularly advises on the Biocidal Products Regulation (product authorization, active substance renewal approval procedure, inclusion into the Article 95 BPR List, derogations under Article 55(1) BPR) and the CLP Regulation (classification issues of multi-constituent mineral substances), as well as litigating cases before the European Chemicals Agency (ECHA) Board of Appeal.

In the EU product law area, Preslava's practice covers product recalls related to food, food contact materials, plastics, packaging, electronics, medical devices, construction products, and waste and recycling. Preslava's extensive experience also includes advising on occupational health and safety issues, general product safety, product liability, EU standardization, and technical harmonization.

In the leading independent legal directory, The Legal 500 Europe, Middle East & Africa (EMEA), 2022 edition, clients reported: "Ursula Schliessner and Preslava Dilkova work well together as a team of specialists always giving the right guidance."

担当案件

  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • International chemicals producer conducts internal auditJones Day is advising an international chemicals producer in conducting a multi-national internal antitrust audit.
  • UPL acquires Arysta LifeScience from Platform Specialty Products Corporation for $4.2 billionJones Day advised UPL Limited ("UPL"), a leading global generic agrochemical company based in India, in connection with its subsidiary, UPL Corporation Limited’s, US$4.2 billion acquisition and related $3 billion term financing of Arysta Lifescience Inc. (“Arysta”), a global provider of crop protection solutions, including bio-solutions and seed treatment, from NYSE listed Platform Specialty Products Corporation (“Platform”).
  • Arsenal Capital Partners sells IGM Resins to AstorgJones Day advised Arsenal Capital Partners (“ACP”) on the full shop auction of IGM Resins Cooperative U.A. and its group (“IGM”) to European private equity firm Astorg as the successful bidder.
    •

    November 2023 Commentary

    Reversal of Burden of Proof Under Proposal for a New EU Product Liability Directive

    May 2021 Alert

    European Commission Update: The Future REACH Revision and PFAS Restriction

    February 2019 Alert

    French Food Safety Agency Launches Call for Information About Nanomaterials Used in Food

    November 2018 Commentary

    Intentional or Not? Questions Loom Over EU's Proposed Micro-Plastic Particle Restrictions

    September 2018 Alert

    ECHA Proposes to Include 18 New Substances in REACH

    July 2018 Commentary

    Closing the Loop—European Circular Economy Package to Improve Waste Management

    June 2018 Commentary

    The European Commission Proposes Restrictions on Single Use Plastics

    出版物情報

    Publications Prior to Jones Day

    The New Procedural Regulation in State Aid - Whether ''Modernization'' is in the Right Direction? European Competition Law Review, Thomson Reuters, 2014 volume 35, issue 2.

    送信する前の注意事項：

    www.jonesday.comに掲載されている情報は、一般的な使用を目的としており、法的アドバイスを目的としたものではありません。このEmailを送信することにより、弁護士を含む専門家・依頼者の関係を構築することを意図するものではなく、このEmailの受領はそのような関係を構築するものではありません。当事務所に送信されたいかなる情報も、業務委託契約を結ばない限り、弁護士等が依頼者に対して守秘義務を負う機密事項として取り扱われることはありません。このEmailの送信者は以上の注意事項の内容を読み、理解したものと判断します。